ABOUT LINK ALTERNATIF MBL77

Not all sufferers with CLL have to have therapy. Despite all recent advances, the iwCLL nevertheless recommends watchful observation for individuals with asymptomatic sickness.86 This advice is predicated on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR